Peter C. Farrell - 24 Nov 2025 Form 4 Insider Report for RESMED INC (RMD)

Reporting relationship: Director
Issuer ticker: RMD
Reported as of: 24 Nov 2025
Net transaction value: +$333,442
SEC form: 4
Accepted by SEC: 26 Nov 2025, 15:26:53 UTC
Prior SEC filing: 24 Nov 2025
Next SEC filing: 04 Dec 2025
Source filing: View source filing
Reporting owner signature: /s/ Michael J. Rider, attorney-in-fact for Mr. Farrell

Key filing fact

Peter C. Farrell filed Form 4 for RESMED INC (RMD) on 26 Nov 2025.

Key facts

This page summarizes Peter C. Farrell's Form 4 filing for RESMED INC (RMD).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 26 Nov 2025, 15:26.

Change

Previous filing in this sequence was filed on 24 Nov 2025.
Current net transaction value: +$333,442.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001186102 Primary reporting owner

FARRELL PETER C

Relationship: Director
Address: 9001 SPECTRUM CENTER BLVD., SAN DIEGO
Signature: /s/ Michael J. Rider, attorney-in-fact for Mr. Farrell
Signature date: 26 Nov 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RMD holding

ResMed Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 70,773
Date: 24 Nov 2025
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

RMD transaction Derivative

ResMed Common Stock Options

Award

Transaction value: $333,442
Shares: +1,331
Change %
Price: $250.52
Shares after: 1,331
Date: 24 Nov 2025
Ownership: Direct
Underlying class: ResMed Common Stock
Underlying amount: 1,331
Exercise price: $250.52
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents the date on which options first become exercisable. The options vest on the earlier of (i) November 11, 2026, or (ii) the date of the first annual meeting of stockholders of the Company following the Grant Date.